NOI-Service and Maintenance of our BD Fortessa Flo
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, has issued a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation. The agency intends to award a firm fixed-price contract to Becton, Dickinson, and Company for the service and maintenance of BD Fortessa Flow Cytometry equipment at the NIH/NIAID, Bethesda, MD. This acquisition is not expected to exceed the simplified acquisition threshold. Proposals are due June 19, 2026, at 1:00 PM EST.
Scope of Work
This requirement covers the service and maintenance of BD Fortessa Flow Cytometry equipment used by the NIH, Laboratory of Molecular Immunology (LMI). Key services include:
- Emergency repair service, including labor, travel, and replacement parts (excluding consumables).
- One planned maintenance inspection per service period.
- Approximately 2 hours of annual preventative maintenance tasks by field service application specialists.
- Provision of all necessary services, qualified personnel, material, equipment, and facilities.
- Technical performance by Original Equipment Manufacturer (OEM) factory-trained technicians, using OEM certified parts and software.
- Submission of written progress reports.
- Compliance with Section 508 of the Rehabilitation Act.
Contract & Timeline
- Contract Type: Firm Fixed-Price
- Period of Performance: July 10, 2026, to July 9, 2027
- Estimated Value: Not specified, but expected not to exceed the simplified acquisition threshold.
- Set-Aside: Not set aside for small business (NAICS Code: 811210, Small Business Size Standard: Other Than Small Business).
- Proposal Due: June 19, 2026, 1:00 PM EST
- Published: June 9, 2026
Submission & Evaluation
Responses must include sufficient information to demonstrate capability, such as unit price, list price, shipping costs, delivery timeframe, F.O.B. point, and product details. Offerors must provide a completed FAR 52.212-3, Offeror Representations and Certifications—Commercial Items. Evaluation factors may include past performance, technical capability, special features, lifecycle, warranty, maintenance availability, and environmental/energy efficiency. Respondents claiming to be manufacturers or authorized resellers must provide specific product and documentation details. Offerors must include their Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification, and be registered in the System for Award Management (SAM). Responses may be submitted electronically.
Additional Notes
This is a non-competitive acquisition under the authority of FAR 12.603 and 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The intended awardee is Becton, Dickinson, and Company. The delivery location is NIH/NIAID, 9000 ROCKVILLE PIKE, BLDG 10, BETHESDA MD 20892-0001. The Point of Contact is John Johnson, Program Specialist, at johnsonjr@mail.nih.gov or 66-312-5580.